Results 141 to 150 of about 190,106 (204)

Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer. [PDF]

BMC Cancer
Wang X, Xu X, Fang S, Shi X, Yang Y.
europepmc   +1 more source

APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial. [PDF]

JCO Precis Oncol
Shi X, Shetty AC, Wang J, Song Y, Sutera PA, Deek MP, Patel KR, Madan RA, Tang C, Proudfoot J, Davicioni E, Hussain A, Nguyen P, Sweeney C, Boytim E, Lacuna KP, Ryan CJ, Antonarakis ES, Tran PT, Hwang J.   +19 more
europepmc   +1 more source

Effects of Surgical and Medical Androgen Deprivation on Bladder Remodeling and Steroid Receptor Expression: An Experimental Rat Study. [PDF]

Neurourol Urodyn
Yenmez MK, Sevinç C, Güler Y.
europepmc   +1 more source

Androgen Receptor Point Mutations: A Mechanism of Therapeutic Resistance and a Framework for Rational Drug Design. [PDF]

Cancers (Basel)
Colah A, Ferková S, Zhang H, Liu G, MacGillivray L, Boudreault PL, Ricke W.   +6 more
europepmc   +1 more source

Abiraterone-Induced Hypokalemia and Hypophosphatemia: A Case Report. [PDF]

Cureus
Safi A, Fayyaz A, Veerban F, Jahangir S, Vishal H, Akatibo E, Kouyate G, Mallappallil M, Puri I, Mohamed I, Azhar M.   +10 more
europepmc   +1 more source

Precision Targeted Therapy for PCOS: Emerging Drugs, Translational Challenges, and Future Opportunities. [PDF]

Biomedicines
Wu X, Yi W, Liu X.
europepmc   +1 more source

Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. [PDF]

Research (Wash D C)
Ye J, Xie Y, Wang J, Wu R, Li D, Yoo KH, Wusiman D, Cho WC, Lyu Z, Feng D.   +9 more
europepmc   +1 more source

Stress-related disorders and nonpeptidic CRH antagonists. [PDF]

Hormones (Athens)
Vlachakis D, Chrousos GP.
europepmc   +1 more source

Longitudinal [¹⁸F]FDG PET/MR Assessment of Arterial Inflammation in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy. [PDF]

Circ Cardiovasc Imaging
Xue S, Hu C, Li L, Einspieler H, Kiss A, Podesser BK, Bergler-Klein J, Hacker M, Li X, Zhou X, Liu J.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recent Developments in Androgen Receptor Antagonists

Archiv Der Pharmazie, 2015
The androgen receptor (AR), a ligand‐dependent transcription factor that regulates the expression of a series of downstream target genes after the binding of androgens, has been a target for the discovery of drugs used to treat prostate cancer. Prostate cancer always progresses to castration‐resistant prostate cancer after a period of androgen ...
Daoguang Zhang, Guisen Zhao
exaly   +3 more sources